Talha Badar, Hematology/Oncology specialist at Mayo Clinic, shared an article by Bingqian Jiang, et al. on X:
“Predictors of CNS relapse in APL:
- Incidence 1.4%.
- Majority of these pts had FLT3 mutation or intracranial hemorrhage at diagnosis/during induction.
- Median time to CNS relapse 22 mo.
- No difference in incidence with or without anthracycline based induction.”
Characteristics and predictors of central nervous system relapse in newly diagnosed acute promyelocytic leukemia in the era of arsenic: a 13-year monocenter cohort study.
Authors: Bingqian Jiang, et al.
